|
Volumn 29, Issue 12, 2011, Pages 1068-
|
Newsmaker: Zafgen.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOPEPTIDASE;
ANTIOBESITY AGENT;
ENZYME INHIBITOR;
GLYCOPROTEIN;
METAP2 PROTEIN, HUMAN;
COMMERCIAL PHENOMENA;
DRUG ANTAGONISM;
DRUG INDUSTRY;
ECONOMICS;
ENZYMOLOGY;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
NEOVASCULARIZATION (PATHOLOGY);
NOTE;
AMINOPEPTIDASES;
ANTI-OBESITY AGENTS;
DRUG INDUSTRY;
ENZYME INHIBITORS;
GLYCOPROTEINS;
HUMANS;
MOLECULAR TARGETED THERAPY;
NEOVASCULARIZATION, PATHOLOGIC;
SMALL BUSINESS;
MLCS;
MLOWN;
|
EID: 84862596274
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1211-1068 Document Type: Note |
Times cited : (3)
|
References (0)
|